These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
403 related articles for article (PubMed ID: 30986800)
1. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors. Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800 [TBL] [Abstract][Full Text] [Related]
2. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects. Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536 [TBL] [Abstract][Full Text] [Related]
3. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study. Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501 [TBL] [Abstract][Full Text] [Related]
4. DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors. de Kock L; Terzic T; McCluggage WG; Stewart CJR; Shaw P; Foulkes WD; Clarke BA Am J Surg Pathol; 2017 Sep; 41(9):1178-1187. PubMed ID: 28654427 [TBL] [Abstract][Full Text] [Related]
5. Pediatric Sertoli-Leydig Cell Tumors of the Ovary: An Integrated Study of Clinicopathological Features, Pan-cancer-Targeted Next-generation Sequencing and Chromosomal Microarray Analysis From a Single Institution. Yang B; Chour W; Salazar CG; Zamiara P; Schmidt RJ; Raca G; Shillingford N; Zhou S; Warren M; Parham DM; Pawel B; Wang LL Am J Surg Pathol; 2024 Feb; 48(2):194-203. PubMed ID: 37946548 [TBL] [Abstract][Full Text] [Related]
6. Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs. McCluggage WG; Rivera B; Chong AS; Clarke BA; Schultz KAP; Dehner LP; Tchrakian N; Apellaniz-Ruiz M; Gilks CB; Kommoss F; Stewart CJR; Foulkes WD Am J Surg Pathol; 2023 Apr; 47(4):490-496. PubMed ID: 36583307 [TBL] [Abstract][Full Text] [Related]
7. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary. Onder S; Hurdogan O; Bayram A; Yilmaz I; Sozen H; Yavuz E Virchows Arch; 2021 Aug; 479(2):317-324. PubMed ID: 33566167 [TBL] [Abstract][Full Text] [Related]
8. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors. Conlon N; Schultheis AM; Piscuoglio S; Silva A; Guerra E; Tornos C; Reuter VE; Soslow RA; Young RH; Oliva E; Weigelt B Mod Pathol; 2015 Dec; 28(12):1603-12. PubMed ID: 26428316 [TBL] [Abstract][Full Text] [Related]
9. Detection of the DICER1 hotspot mutation alongside immunohistochemical analysis may provide a better diagnostic measure for ovarian Sertoli-Leydig cell tumors. Zhang X; Shen D; Wang Y Pathol Res Pract; 2018 Sep; 214(9):1370-1375. PubMed ID: 30072170 [TBL] [Abstract][Full Text] [Related]
10. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry. Schultz KAP; Harris AK; Finch M; Dehner LP; Brown JB; Gershenson DM; Young RH; Field A; Yu W; Turner J; Cost NG; Schneider DT; Stewart DR; Frazier AL; Messinger Y; Hill DA Gynecol Oncol; 2017 Dec; 147(3):521-527. PubMed ID: 29037807 [TBL] [Abstract][Full Text] [Related]
17. Sertoli-Leydig cell tumor in two siblings with DICER1 syndrome: A case report and literature review. Zhang Y; Ren M; Hong Y; Zhong Y; Cong X; Chen C; Liu Z; Man Y; Yang L Medicine (Baltimore); 2020 Jul; 99(27):e20806. PubMed ID: 32629665 [TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors. Yuan Z; Huo X; Jiang D; Yu M; Cao D; Wu H; Shen K; Yang J; Zhang Y; Zhou H; Wang Y Oncologist; 2020 Sep; 25(9):e1396-e1405. PubMed ID: 32557933 [TBL] [Abstract][Full Text] [Related]
19. [Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features]. Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927 [No Abstract] [Full Text] [Related]
20. Testicular Neoplasms With Sex Cord and Stromal Components Harbor a Recurrent Pattern of Chromosomal Gains. Acosta AM; Sholl LM; Maclean F; Kao CS; Ulbright TM Mod Pathol; 2024 Jan; 37(1):100368. PubMed ID: 37871653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]